EcoDrugPlus

Calcium Voltage-Gated Channel Subunit Alpha1 B

Ensembl ID : ENSCCRG00000034776
Gene Symbol: CACNA1B
1 Cross references
212 Possible Orthologues:

Calcium Voltage-Gated Channel Subunit Alpha1 D

Ensembl ID : ENSCCRG00000035647
Gene Symbol: CACNA1D
1 Cross references
209 Possible Orthologues:

Cannabinoid Receptor 1

Ensembl ID : ENSCCRG00000081020
Gene Symbol: CNR1
1 Cross references
151 Possible Orthologues:

Cannabinoid Receptor 1

Ensembl ID : ENSCCRG00000064308
Gene Symbol: CNR1
1 Cross references
151 Possible Orthologues:

Cannabinoid Receptor 2

Ensembl ID : ENSCCRG00000055081
Gene Symbol: CNR2
1 Cross references
186 Possible Orthologues:

Cannabinoid Receptor 2

Ensembl ID : ENSCCRG00000055283
Gene Symbol: CNR2
1 Cross references
185 Possible Orthologues:

Carbonic Anhydrase 12

Ensembl ID : ENSCCRG00000082665
Gene Symbol: CA12
1 Cross references
213 Possible Orthologues:

Carbonic Anhydrase 6

Ensembl ID : ENSCCRG00000015506
Gene Symbol: CA6
1 Cross references
227 Possible Orthologues:

Carbonic Anhydrase 6

Ensembl ID : ENSCCRG00000047899
Gene Symbol: CA6
1 Cross references
227 Possible Orthologues:

Carbonic Anhydrase Iv A

Ensembl ID : ENSCCRG00000067028
Gene Symbol: CA4A
1 Cross references
211 Possible Orthologues:

Carbonic Anhydrase Iv A

Ensembl ID : ENSCCRG00000030049
Gene Symbol: CA4A
1 Cross references
211 Possible Orthologues:

Carbonic Anhydrase Iv B

Ensembl ID : ENSCCRG00000033589
Gene Symbol: CA4B
1 Cross references
198 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).